WHO, Partners Launch Guidance On Developing Digital Health Interventions With, For Young People October 29, 2020 News Summary WHO: Young people and digital health interventions: working together to design better “WHO and partners launch new guidance on designing digital health interventions with and for young people. Digital tools are an increasingly popular approach to improving health worldwide — particularly among adolescents and young people, who are accessing the…
CDC, Partners Work To Mitigate Impacts Of COVID-19 On HIV Services In Tanzania October 29, 2020 News Summary CDC’s “Our Global Voices”: CDC Tanzania and partners: Ensure HIV services amidst the COVID-19 pandemic This post discusses the challenges posed by the COVID-19 pandemic for routine HIV prevention, testing, and treatment services in Tanzania, as well as the efforts of the U.S. Centers for Disease Control and Prevention (CDC),…
KFF Provides Resources On Global, Domestic Aspects Of Pandemic October 29, 2020 News Summary KFF: U.S. Global Funding for COVID-19 by Country and Region This analysis examines the status of U.S. global COVID-19 country, regional, and worldwide funding to assess how much has been committed to date and where it has been directed (Moss et al., 10/23). KFF: COVID-19 Coronavirus Tracker — Updated as…
USAID Launches Over The Horizon Strategic Review To Examine World Altered By COVID-19 October 29, 2020 News Summary USAID: Preparing For A World Altered By COVID-19 “COVID-19 has had — and will continue to have — an extraordinary impact on the people, places, and partners to which USAID provides assistance. In light of this, the Agency must prepare for lasting changes to the development and humanitarian landscape in…
Development Banks Must Show Transparency, Accountability For Pandemic Funding, Uphold Rights Of Journalists, Opinion Piece Urges October 29, 2020 News Summary Devex: Opinion: No space for dissent — how development banks are supporting governments that silence journalists Lorena Cotza, communications lead at the Coalition for Human Rights in Development “Since the COVID-19 pandemic started, multilateral development banks have committed nearly $100 billion for hundreds of coronavirus-related projects. But are these funds…
USAID To Provide $20M Over 5 Years To CEPI; Funds Subject To Congressional Approval October 28, 2020 News Summary Homeland Preparedness News: USAID offers $20M in aid to CEPI for infectious diseases vaccine development “The Coalition for Epidemic Preparedness Innovations (CEPI) gained a $20 million investment from the U.S. Agency for International Development (USAID) last week to support the development of vaccines targeting emerging infectious diseases. These funds will…
Sanofi, GSK To Provide Potential COVID-19 Vaccine To COVAX; Vaccine Nationalism Poses Challenges; Russia Applies For WHO Emergency Use Of Its Sputnik V Vaccine October 28, 2020 News Summary AP: Sanofi, GSK to provide COVID-19 vaccine to global alliance “Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around the world equal access to coronavirus vaccines…” (10/28). Bloomberg: Sanofi, Glaxo to Supply…
Pfizer CEO Urges Patience In COVID-19 Vaccine Development, Announces Trial Goals Taking Longer To Reach October 28, 2020 News Summary Financial Times: Pfizer urges patience in ‘last mile’ of Covid-19 vaccine process “Pfizer’s chief executive has urged patience in the ‘last mile’ of Covid-19 vaccine development, after the timeline for an early look at whether a late-stage trial shows its vaccine works was poised to slip into November. Albert Bourla said…
NIH Closes Clinical Trial Assessing Eli Lilly Antibody Treatment For Hospitalized COVID-19 Patients Due To Lack Of Clinical Benefit October 28, 2020 News Summary The Hill: NIH halts study of Eli Lilly antibody drug for treating hospitalized COVID-19 patients “Federal researchers have ended a study into the effectiveness of Eli Lilly’s antibody treatment for hospitalized COVID-19 patients due to a lack of effectiveness. The National Institute of Allergy and Infectious Diseases (NIAID), which is…